Vestal Point Capital, LP
Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Abivax SA(ABVX) | 0 | 1,000,000 | +1,000,000 | 0 | 84,900,000 | 3.85% | +84,900,000 |
| Ascendis Pharma A/S(ASND) | 200,000 | 600,000 | +400,000 | 34,520,000 | 119,286,000 | 5.41% | +84,766,000 |
| Becton Dickinson & Co(BDX) | 25,000 | 325,000 | +300,000 | 4,306,250 | 60,830,250 | 2.76% | +56,524,000 |
| Repligen Corp(RGEN) | 0 | 400,000 | +400,000 | 0 | 53,468,000 | 2.43% | +53,468,000 |
| Ionis Pharmaceuticals Inc(IONS) | 500,000 | 1,075,000 | +575,000 | 19,755,000 | 70,326,500 | 3.19% | +50,571,500 |
| Dexcom Inc(DXCM) | 0 | 650,000 | +650,000 | 0 | 43,738,500 | 1.98% | +43,738,500 |
| Globus Medical Inc(GMED) | 500,000 | 1,250,000 | +750,000 | 29,510,000 | 71,587,500 | 3.25% | +42,077,500 |
| Biogen Inc(BIIB) | 0 | 275,000 | +275,000 | 0 | 38,522,000 | 1.75% | +38,522,000 |
| Alcon AG(ALC) | 525,000 | 1,100,000 | +575,000 | 46,347,000 | 81,961,000 | 3.72% | +35,614,000 |
| Bicara Therapeutics Inc | 5,000,000 | 5,100,000 | +100,000 | 46,450,000 | 80,529,000 | 3.65% | +34,079,000 |
| Rapport Therapeutics Inc(RAPP) | 0 | 950,000 | +950,000 | 0 | 28,215,000 | 1.28% | +28,215,000 |
| Dyne Therapeutics Inc(DYN) | 727,500 | 2,775,000 | +2,047,500 | 6,925,800 | 35,103,750 | 1.59% | +28,177,950 |
| Disc Medicine Inc(IRON) | 140,000 | 500,000 | +360,000 | 7,414,400 | 33,040,000 | 1.50% | +25,625,600 |
| Belite Bio Inc(BLTE) | 0 | 312,500 | +312,500 | 0 | 23,125,000 | 1.05% | +23,125,000 |
| Ultragenyx Pharmaceutical Inc(RARE) | 0 | 750,000 | +750,000 | 0 | 22,560,000 | 1.02% | +22,560,000 |
| Immatics NV(IMTX) | 6,250,000 | 6,350,000 | +100,000 | 33,625,000 | 54,102,000 | 2.45% | +20,477,000 |
| Danaher Corp(DHR) | 50,000 | 150,000 | +100,000 | 9,877,000 | 29,739,000 | 1.35% | +19,862,000 |
| Enliven Therapeutics Inc | 250,000 | 1,160,000 | +910,000 | 5,015,000 | 23,745,200 | 1.08% | +18,730,200 |
| Axsome Therapeutics Inc(AXSM) | 0 | 150,000 | +150,000 | 0 | 18,217,500 | 0.83% | +18,217,500 |
| BioMarin Pharmaceutical Inc(BMRN) | 500,000 | 830,000 | +330,000 | 27,485,000 | 44,952,800 | 2.04% | +17,467,800 |
| Apogee Therapeutics Inc(APGE) | 0 | 425,000 | +425,000 | 0 | 16,885,250 | 0.77% | +16,885,250 |
| Zymeworks Inc(ZYME) | 1,150,000 | 1,765,000 | +615,000 | 14,432,500 | 30,146,200 | 1.37% | +15,713,700 |
| Regeneron Pharmaceuticals Inc(REGN) | 0 | 25,000 | +25,000 | 0 | 14,056,750 | 0.64% | +14,056,750 |
| Cidara Therapeutics Inc | 500,000 | 400,000 | -100,000 | 24,355,000 | 38,304,000 | 1.74% | +13,949,000 |
| Nuvalent Inc(NUVL) | 1,075,000 | 1,100,000 | +25,000 | 82,022,500 | 95,128,000 | 4.32% | +13,105,500 |
| Astria Therapeutics Inc | 4,522,000 | 4,956,000 | +434,000 | 24,237,920 | 36,079,680 | 1.64% | +11,841,760 |
| Taysha Gene Therapies Inc(TSHA) | 3,000,000 | 5,500,000 | +2,500,000 | 6,930,000 | 17,985,000 | 0.82% | +11,055,000 |
| Solid Biosciences Inc | 1,505,000 | 2,975,000 | +1,470,000 | 7,329,350 | 18,355,750 | 0.83% | +11,026,400 |
| Biohaven Ltd(BHVN)(Put) | 0 | 701,700 | +701,700 | 0 | 10,532,517 | — | +10,532,517 |
| Inspire Medical Systems Inc(INSP) | 0 | 135,000 | +135,000 | 0 | 10,017,000 | 0.45% | +10,017,000 |
| Abbott Laboratories | 175,000 | 250,000 | +75,000 | 23,801,750 | 33,485,000 | 1.52% | +9,683,250 |
| Nurix Therapeutics Inc(NRIX) | 2,000,000 | 3,475,000 | +1,475,000 | 22,780,000 | 32,109,000 | 1.46% | +9,329,000 |
| Amicus Therapeutics Inc | 11,900,000 | 9,750,000 | -2,150,000 | 68,187,000 | 76,830,000 | 3.49% | +8,643,000 |
| Lexeo Therapeutics Inc | 3,228,161 | 3,250,000 | +21,839 | 12,977,207 | 21,580,000 | 0.98% | +8,602,793 |
| Tyra Biosciences Inc(TYRA) | 2,655,000 | 2,425,000 | -230,000 | 25,408,350 | 33,925,750 | 1.54% | +8,517,400 |
| Black Diamond Therapeutics Inc | 5,600,000 | 5,550,000 | -50,000 | 13,888,000 | 21,034,500 | 0.95% | +7,146,500 |
| CG Oncology Inc(CGON) | 0 | 175,000 | +175,000 | 0 | 7,049,000 | 0.32% | +7,049,000 |
| Tvardi Therapeutics Inc | 0 | 167,000 | +167,000 | 0 | 6,507,990 | 0.30% | +6,507,990 |
| Monte Rosa Therapeutics Inc(GLUE) | 0 | 800,000 | +800,000 | 0 | 5,928,000 | 0.27% | +5,928,000 |
| GSK PLC(GSK) | 0 | 125,000 | +125,000 | 0 | 5,395,000 | 0.24% | +5,395,000 |
| Novocure Ltd(NVCR) | 0 | 400,000 | +400,000 | 0 | 5,168,000 | 0.23% | +5,168,000 |
| Agios Pharmaceuticals Inc(AGIO) | 0 | 127,000 | +127,000 | 0 | 5,097,780 | 0.23% | +5,097,780 |
| Applied Therapeutics Inc | 11,500,000 | 14,250,000 | +2,750,000 | 3,577,650 | 8,619,825 | 0.39% | +5,042,175 |
| Lantheus Holdings Inc(LNTH) | 50,000 | 170,000 | +120,000 | 4,093,000 | 8,719,300 | 0.40% | +4,626,300 |
| Myriad Genetics Inc | 0 | 600,000 | +600,000 | 0 | 4,338,000 | 0.20% | +4,338,000 |
| Establishment Labs Holdings In(ESTA) | 0 | 100,000 | +100,000 | 0 | 4,099,000 | 0.19% | +4,099,000 |
| Kodiak Sciences Inc(KOD) | 0 | 250,000 | +250,000 | 0 | 4,092,500 | 0.19% | +4,092,500 |
| Beta Bionics Inc | 550,000 | 600,000 | +50,000 | 8,008,000 | 11,922,000 | 0.54% | +3,914,000 |
| Arcus Biosciences Inc(RCUS) | 0 | 250,000 | +250,000 | 0 | 3,400,000 | 0.15% | +3,400,000 |
| Scholar Rock Holding Corp(SRRK) | 1,500,000 | 1,500,000 | 0 | 53,130,000 | 55,860,000 | 2.53% | +2,730,000 |
| Passage Bio Inc | 0 | 305,000 | +305,000 | 0 | 2,449,150 | 0.11% | +2,449,150 |
| Arcutis Biotherapeutics Inc(ARQT) | 95,000 | 200,000 | +105,000 | 1,331,900 | 3,770,000 | 0.17% | +2,438,100 |
| Voyager Therapeutics Inc | 1,475,000 | 1,475,000 | 0 | 4,587,250 | 6,888,250 | 0.31% | +2,301,000 |
| Ventyx Biosciences Inc | 2,000,000 | 2,050,000 | +50,000 | 4,280,000 | 6,375,500 | 0.29% | +2,095,500 |
| Alto Neuroscience Inc(ANRO) | 950,000 | 950,000 | 0 | 2,090,000 | 3,819,000 | 0.17% | +1,729,000 |
| Alector Inc | 976,992 | 980,000 | +3,008 | 1,367,789 | 2,900,800 | 0.13% | +1,533,011 |
| Pulmonx Corp | 0 | 830,000 | +830,000 | 0 | 1,344,600 | 0.06% | +1,344,600 |
| Engene Holdings Inc | 370,000 | 370,000 | 0 | 1,346,800 | 2,527,100 | 0.11% | +1,180,300 |
| Sutro Biopharma Inc | 2,600,000 | 2,600,000 | 0 | 1,856,140 | 2,257,840 | 0.10% | +401,700 |
| Fate Therapeutics Inc | 2,515,000 | 2,515,000 | 0 | 2,816,800 | 3,168,900 | 0.14% | +352,100 |
| OnKure Therapeutics Inc | 635,000 | 635,000 | 0 | 1,517,650 | 1,746,250 | 0.08% | +228,600 |
| MacroGenics Inc | 280,000 | 280,000 | 0 | 338,800 | 470,400 | 0.02% | +131,600 |
| Tenax Therapeutics Inc | 53,439 | 53,439 | 0 | 307,809 | 406,671 | 0.02% | +98,862 |
| Traws Pharma Inc | 149,800 | 150,000 | +200 | 221,704 | 277,500 | 0.01% | +55,796 |
| Day One Biopharmaceuticals Inc | 3,000,000 | 2,675,000 | -325,000 | 19,500,000 | 18,858,750 | 0.86% | -641,250 |
| Atara Biotherapeutics Inc | 94,085 | 0 | -94,085 | 726,336 | 0 | — | -726,336 |
| Viridian Therapeutics Inc(VRDN) | 100,000 | 0 | -100,000 | 1,398,000 | 0 | — | -1,398,000 |
| Passage Bio Inc | 6,100,000 | 0 | -6,100,000 | 2,441,830 | 0 | — | -2,441,830 |
| Neurocrine Biosciences Inc(NBIX) | 30,000 | 0 | -30,000 | 3,770,700 | 0 | — | -3,770,700 |
| Celldex Therapeutics Inc(CLDX) | 1,750,000 | 1,205,000 | -545,000 | 35,612,500 | 31,173,350 | 1.41% | -4,439,150 |
| Zimmer Biomet Holdings Inc(ZBH) | 50,000 | 0 | -50,000 | 4,560,500 | 0 | — | -4,560,500 |
| Travere Therapeutics Inc(TVTX) | 355,000 | 0 | -355,000 | 5,254,000 | 0 | — | -5,254,000 |
| Nyxoah SA | 1,402,002 | 1,107,413 | -294,589 | 10,486,975 | 5,094,100 | 0.23% | -5,392,875 |
| Bruker Corp(BRKR) | 500,000 | 440,000 | -60,000 | 20,600,000 | 14,295,600 | 0.65% | -6,304,400 |
| Geron Corp(GERN) | 23,775,000 | 17,225,000 | -6,550,000 | 33,522,750 | 23,598,250 | 1.07% | -9,924,500 |
| Thermo Fisher Scientific Inc(TMO) | 25,000 | 0 | -25,000 | 10,136,500 | 0 | — | -10,136,500 |
| Savara Inc(SVRA) | 11,015,000 | 4,015,000 | -7,000,000 | 25,114,200 | 14,333,550 | 0.65% | -10,780,650 |
| Crinetics Pharmaceuticals Inc(CRNX) | 1,500,000 | 750,000 | -750,000 | 43,140,000 | 31,237,500 | 1.42% | -11,902,500 |
| Dianthus Therapeutics Inc(DNTH) | 3,200,000 | 1,180,000 | -2,020,000 | 59,616,000 | 46,433,000 | 2.11% | -13,183,000 |
| Revolution Medicines Inc(RVMD) | 1,200,000 | 630,000 | -570,000 | 44,148,000 | 29,421,000 | 1.33% | -14,727,000 |
| Perrigo Co PLC(PRGO) | 625,000 | 0 | -625,000 | 16,700,000 | 0 | — | -16,700,000 |
| Medtronic PLC(MDT) | 195,000 | 0 | -195,000 | 16,998,150 | 0 | — | -16,998,150 |
| Xenon Pharmaceuticals Inc(XENE) | 2,000,000 | 1,100,000 | -900,000 | 62,600,000 | 44,165,000 | 2.00% | -18,435,000 |
| Cogent Biosciences Inc(COGT) | 3,080,000 | 0 | -3,080,000 | 22,114,400 | 0 | — | -22,114,400 |
| Edwards Lifesciences Corp | 300,000 | 0 | -300,000 | 23,463,000 | 0 | — | -23,463,000 |
| Structure Therapeutics Inc | 1,200,000 | 0 | -1,200,000 | 24,888,000 | 0 | — | -24,888,000 |
| Cooper Cos Inc/The(COO) | 350,000 | 0 | -350,000 | 24,906,000 | 0 | — | -24,906,000 |
| MoonLake Immunotherapeutics(MLTX) | 550,000 | 0 | -550,000 | 25,960,000 | 0 | — | -25,960,000 |
| Exact Sciences Corp(EXK) | 700,000 | 75,000 | -625,000 | 37,198,000 | 4,103,250 | 0.19% | -33,094,750 |
| uniQure NV(QURE) | 3,700,000 | 225,000 | -3,475,000 | 51,578,000 | 13,133,250 | 0.60% | -38,444,750 |
| KalVista Pharmaceuticals Inc | 4,675,000 | 750,000 | -3,925,000 | 52,850,875 | 9,135,000 | 0.41% | -43,715,875 |
| Vera Therapeutics Inc(VERA) | 3,100,000 | 760,000 | -2,340,000 | 73,036,000 | 22,085,600 | 1.00% | -50,950,400 |
| GE HealthCare Technologies Inc(GEHC) | 700,000 | 0 | -700,000 | 51,849,000 | 0 | — | -51,849,000 |
| Cytokinetics Inc(CYTK) | 2,975,000 | 725,000 | -2,250,000 | 98,294,000 | 39,846,000 | 1.81% | -58,448,000 |
| Jazz Pharmaceuticals PLC(JAZZ) | 1,200,000 | 500,000 | -700,000 | 127,344,000 | 65,900,000 | 2.99% | -61,444,000 |
| Arcellx Inc | 2,750,000 | 1,250,000 | -1,500,000 | 181,087,500 | 102,625,000 | 4.66% | -78,462,500 |